Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Longo

Showing results (31-40 of 484) with videos related to

Pageof 49
Sort By:
Nature|September 4, 1980
T-cell specificity for H-2 and Ir gene phenotype correlates with the phenotype of thymic antigen-presenting cellsD L Longo, R H Schwartz
The Journal of Experimental Medicine|June 1, 1980
Gene complementation. Neither Ir-GLphi gene need be present in the proliferative T cell to generate an immune response to Poly(Glu55Lys36Phe9)nD L Longo, R H Schwartz
Investigative Radiology|August 1, 1993
Hodgkin's disease in adults. Part IW J Urba, D L Longo
Bailliere'S Clinical Haematology|September 1, 1996
Treatment of relapsed Hodgkin's diseaseB L Gause, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 11, 1991
LymphomasD L Longo, V T Devita
Comprehensive Therapy|December 1, 1991
Biological response modifiers in breast cancerJ E Janik, D L Longo
The New England Journal of Medicine|March 5, 1992
Hodgkin's diseaseW J Urba, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
Adoptive cellular therapyW J Urba, D L Longo
Seminars in Hematology|May 13, 1999
T-small lymphocyte disordersN L Bartlett, D L Longo
Immunology Today|July 6, 2000
Growth hormone as an immunomodulating therapeutic agentW J Murphy, D L Longo
Pageof 49

Showing results (31-40 of 484) with videos related to

Sort By:
Pageof 49
Nature|September 4, 1980
T-cell specificity for H-2 and Ir gene phenotype correlates with the phenotype of thymic antigen-presenting cellsD L Longo, R H Schwartz
The Journal of Experimental Medicine|June 1, 1980
Gene complementation. Neither Ir-GLphi gene need be present in the proliferative T cell to generate an immune response to Poly(Glu55Lys36Phe9)nD L Longo, R H Schwartz
Investigative Radiology|August 1, 1993
Hodgkin's disease in adults. Part IW J Urba, D L Longo
Bailliere'S Clinical Haematology|September 1, 1996
Treatment of relapsed Hodgkin's diseaseB L Gause, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 11, 1991
LymphomasD L Longo, V T Devita
Comprehensive Therapy|December 1, 1991
Biological response modifiers in breast cancerJ E Janik, D L Longo
The New England Journal of Medicine|March 5, 1992
Hodgkin's diseaseW J Urba, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
Adoptive cellular therapyW J Urba, D L Longo
Seminars in Hematology|May 13, 1999
T-small lymphocyte disordersN L Bartlett, D L Longo
Immunology Today|July 6, 2000
Growth hormone as an immunomodulating therapeutic agentW J Murphy, D L Longo
Pageof 49